Skip to main content
Domainex
  • About
    • About
    • Track Record
    • Case Studies
    • Testimonials
    • Awards & Accreditations
    • Our team
    • Board members
    • Investors
    • Contact us
  • Solutions
    • Services
      • Biosciences
        • ADME and Bioanalytical Sciences
        • Assay Development and Transfer
        • Biochemistry / Enzymology
        • Biophysics
        • Cellular Biology
        • Compound screening and cascade design
        • Cryo-EM
        • Project Management and Consultancy Services
        • Protein Expression
        • Structural Biology
        • X-ray Crystallography
      • Chemistry
        • Analytical Chemistry
        • Direct-to-Biology (D2B)
        • Medicinal Chemistry
        • Synthetic Chemistry
      • Integrated Drug Discovery
        • Fragment based drug discovery
        • Hit to Lead
        • Hit Identification
        • Lead Optimisation
        • Project Management and Consultancy Services
        • Structure Based Drug Design (SBDD)
        • Lead Discovery
      • Computer Aided Drug Design
        • Computational Chemistry and Biology
        • Virtual Screening
      • Hit Identification
        • Fragment Screening
        • High Throughput Screening
        • Virtual Screening
    • Target Classes and Modalities
      • Biotherapeutics
      • Covalent Inhibitors
      • GPCRs
      • Ion Channels
      • Kinases
      • Methyltransferases
      • Molecular Glues
      • Prodrugs
      • Proteases
      • Protein-Protein Interactions
      • Targeted Protein Degradation
    • Therapeutic Areas
      • Anti-infectives
      • Cardiovascular
      • CNS
      • Immuno-Oncology
      • Inflammatory diseases
      • Oncology
      • Respiratory
    • A-Z
      • A
        • Aldehyde Oxidase Stability Assay
        • Analytical Chemistry
        • Anti-infectives
        • Assay Development and Transfer
      • B
        • Biochemistry / Enzymology
        • Biophysics
        • Biotherapeutics
      • C
        • CDH (Target Gene Fragmentation)
        • CNS
        • Caco-2 Permeability Assay
        • Cardiovascular
        • Cellular Biology
        • Compound screening and cascade design
        • Computational Chemistry and Biology
        • Covalent Inhibitors
        • Cryo-EM
      • D
        • Differential Scanning Fluorimetry (DSF) and nanoDSF Services
        • Direct-to-Biology (D2B)
        • Dynamic Light Scattering (DLS)
      • E
        • Experimental Polar Surface Area (EPSA) Assay
      • F
        • Flow Cytometry
        • Fragment based drug discovery
      • G
        • GPCRs
        • GSH Reactivity Assay
      • H
        • Hepatocyte Clearance/Stability Assay
        • High Throughput Screening
        • Hit Identification
        • Hit to Lead
      • I
        • Immuno-Oncology
        • Inflammatory diseases
        • Innovative Polymer Lipid Particle (PoLiPa) Technology
        • Integrated Drug Discovery
        • Ion Channels
        • Isothermal Titration Calorimetry (ITC)
      • K
        • Kinact / KI Assay for Irreversible Covalent Compounds
        • Kinases
      • L
        • Lead Optimisation
        • Ligand binding assays by Surface Plasmon Resonance (SPR) and/or Grating-Coupled Interferometry (GCI)
      • M
        • Medicinal Chemistry
        • Membrane protein production
        • Methyltransferases
        • Microsomal Clearance/Stability Assay
        • Molecular Glues
      • N
        • Neuroinflammation
      • O
        • Oncology
      • P
        • Photoaffinity Labelling
        • Plasma Protein Binding Assay
        • Plasma Stability Assay
        • Project Management and Consultancy Services
        • Proteases
        • Protein Expression
        • Protein-Protein Interactions
      • R
        • Respiratory
        • Reversible Covalent Inhibitor Binding Assay
      • S
        • Shake Flask LogD
        • Spectral Shift and MST Services
        • Structural Biology
        • Structure Based Drug Design (SBDD)
        • Synthetic Chemistry
      • T
        • Targeted Protein Degradation
        • Targeted Protein Degrader Toolbox
        • Ternary Complex Formation Assays
        • Thermodynamic Solubility Assay
        • Turbidimetric (Kinetic) Solubility Assay
      • V
        • Virtual Screening
      • X
        • X-ray Crystallography
  • Library
    • Articles
    • Brochures
    • Newsletters
    • Posters
    • Presentations & Videos
    • Publications
    • White Papers
    • Webinars
  • News & Events
  • Careers
  • English
  • French
  • Spanish
  • German
  • Italian
  • Japanese
  • Dutch
  • USA
Enquire

Library

Fragment Based Drug Design (FBDD): a fragment hit to drug candidate case study

Presentations & Videos

Challenges and Opportunities in Drug Screening

Presentations & Videos

Biochemical lysine methyltransferase assay – studying low-turnover enzymes

White Papers

Are we seeing long-term shifts in the Scientific Research Landscape?

Presentations & Videos

Grating Coupled Interferometry (GCI) analysis of agonists binding to a membrane protein

Posters

HTRF-based kinase assay for fragment screening and MOA studies

White Papers

Hitting the Right Starting Points for Drug Discovery: Biophysical Screening Methods

Presentations & Videos

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11

Start your next project with Domainex

Contact one of our experts today
Domainex

+44(0) 1223 433180 enquiries@domainex.co.uk

Cyber Essentials - Certified Plus

Domainex is a registered company (number 4336899)

Site and its contents Copyright © Domainex 2025. All rights reserved.

Terms and Conditions | Privacy Policy